Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
netFormulary
Home
Treatment Use
Class
Chapters
News
Reports
Contact
SEARCH
Searching for :
Docetaxel
Open monograph to display formulary status.
Formulary items found
Status
Description
Section
RED
Docetaxel Taxotere
®
Malignant disease and immunosuppression, Taxanes, 08.01.05
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local
BNF
Section
Docetaxel
Docetaxel [Specialist Drug]
Malignant Disease, Cytotoxic Responsive Malignancy, Antineoplastic Drugs Taxanes
Links found
NICE TA101: Prostate cancer (hormone-refractory) - docetaxel
NICE TA109: Breast cancer (early) - docetaxel
NICE TA316: Enzalutamide for metastatic hormone‑relapsed prostate cancer previously treated with a docetaxel‑containing regimen
NICE TA391: Cabazitaxel for hormone-relapsed metastatic prostate cancer treated with docetaxel
NICE TA509: Pertuzumab with trastuzumab and docetaxel for treating HER2-positive breast cancer
NICE TA903: Darolutamide with androgen deprivation therapy and docetaxel for treating hormone-sensitive metastatic prostate cancer